Special Drug Use Investigation for ADOAIR DISKUS COPD (Salmeterol and Fluticasone)
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
To investigate possible problems or questions in safety and effectiveness of salmeterol and
fluticasone in patients with chronic obstructive pulmonary disease (bronchitis chronic /
emphysema). In this special drug use investigation, onset of pneumonia shall be handled as
the priority investigation item.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate